Yervoy 50 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DR26F18AW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,051
Award facts
- Contract value 100% obligated
- $12,051.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,051.22 to AmerisourceBergen Drug Corp for Yervoy (ipilimumab) 50 mg/10 mL vials on November 13, 2025, with completion targeted for December 5, 2025. This firm fixed-price delivery order, which received no set-aside designation, will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader relationship with the federal government as a critical pharmaceutical supplier to military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, specialty drugs, vaccines, and medical supplies to support military healthcare programs worldwide. Yervoy, an immune checkpoint inhibitor used in oncology treatment, represents the type of specialized pharmaceutical commodity the contract encompasses. AmerisourceBergen's federal procurement portfolio demonstrates its competitive standing and capability to meet complex medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DR26F18AW?
SPE2DR26F18AW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F18AW worth?
The government has obligated $12,051 on SPE2DR26F18AW.
Is contract SPE2DR26F18AW an order under another contract?
Yes. SPE2DR26F18AW is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F18AW competed?
The extent of competition for SPE2DR26F18AW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award